CECILIA BATTISTELLI

CECILIA BATTISTELLI
Curriculum Vitae

Place: Roma
Date: 12/4/2025

Part I – General Information
Full Name Cecilia Battistelli
Citizenship Italian
E-mail cecilia.battistelli@uniroma1.it
Spoken Languages Italian (mother tongue), English, French

Part II – Education
Type Institution Notes (Degree, Experience,…)
University graduation Sapienza University of Rome Biology (LS: Genetics and Molecular Biology), full marks and honors
Italian Biological Licensure (ESAME DI STATO) Sapienza University of Rome
PhD Sapienza University of Rome PhD in Human Biology and Genetics

Part III – Appointments

IIIA – Academic Appointments
Start End Institution Position
1/04/2025 Sapienza University of Rome Responsabile del Progetto di IV missione PCTO (Percorsi per le Competenze Trasversali e l'Orientamento) “Una giornata da... biologo al Policlinico Umberto I”

15/07/2024 Sapienza University of Rome Professore Associato SSD BIOS/10-A
22/9/2022 20/6/2024 Sapienza University of Rome Docente esperto per la realizzazione di insegnamenti a elevata innovazione della didattica sulla base della Partecipazione al percorso formativo biennale sull’innovazione della didattica (QUID)
22/04/2024 Sapienza University of Rome Valutazione positiva nell’ambito della procedura di valutazione ai fini della chiamata nel ruolo di professore di seconda fascia, ai sensi dell’art. 24 comma 5 Legge 240/2010 https://web.uniroma1.it/trasparenza/bando/216654_
08/11/2023 Today Sapienza University of Rome Membro Commissione web del Dipartimento Medicina Molecolare
25/10/2023 Today Sapienza University of Rome and partner Universities worldwide Membro del progetto WE4LEAD, progetto Erasmus+ di Capacity Building in Higher Education (CBHE) co-finanziato dalla Comunità Europea e dall’Università di Aix Marseille
15/07/2021 14/07/2024 Sapienza University of Rome Ricercatore a tempo determinato (RTD) tipo B BIO/13
01/05/2018 30/04/2021 Sapienza University of Rome Ricercatore a tempo determinato (RTD) tipo A BIO/13
18/09/2018 18/09/2027 Abilitazione Scientifica Nazionale 05/F1 II FASCIA
01/6/2017 30/04/2018 Sapienza University of Rome Research Fellowship (PI: Prof. Marco Tripodi)
01/4/2016 31/03/2017 Sapienza University of Rome Research Fellowship (PI: Prof. Marco Tripodi)
01/4/2015 31/03/2016 Sapienza University of Rome Research Fellowship (PI: Prof. Marco Tripodi)
01/4/2014 31/03/2015 Sapienza University of Rome Research Fellowship (PI: Prof. Marco Tripodi)
01/3/2013 28/02/2014 Sapienza University of Rome Research Fellowship (PI: Prof. Marco Tripodi)
01/1/2012 31/12/2012 Sapienza University of Rome Research Fellowship (PI: Prof. Marco Tripodi)

IIIB – Other Appointments
Start End Institution Position
01/4/2017 31/05/2017 Pasteur Institute Italy- Cenci Bolognetti Foundation Research Fellowship (PI: Prof. Marco Tripodi)
01/1/2013 28/02/2013 Pasteur Institute Italy- Cenci Bolognetti Foundation Research Fellowship (PI: Prof. Marco Tripodi)
01/11/2011 31/12/2011 Pasteur Institute Italy- Cenci Bolognetti Foundation Research Fellowship (PI: Prof. Rossella Maione)

Part IV – Teaching experience
Year Institution Lecture/Course
2018/2019 Sapienza University of Rome Medicina e Chirurgia (canale C)
Biologia e Genetica I, modulo di Biologia Cellulare (2cfu)
Tecniche di Fisiopatologia Cardio-circolatoria e Perfusione Cardiovascolare
Basi cellulari e molecolari della vita, modulo di Biologia Applicata (2cfu)
Tecniche Ortopediche
Scienze Biomediche I, modulo di Biologia (2cfu)
2019/2020 Sapienza University of Rome Tecniche Ortopediche
Scienze Biomediche I, modulo di Biologia (2cfu)
Tecniche di Fisiopatologia Cardio-circolatoria e Perfusione Cardiovascolare
Basi cellulari e molecolari della vita, modulo di Biologia Applicata (2cfu)
Ostetricia
Basi molecolari e cellulari della vita, modulo di Biologia applicata (2cfu)
2020/2021 Sapienza University of Rome Tecniche Ortopediche
Scienze Biomediche I, modulo di Biologia (2cfu)
Tecniche di Fisiopatologia Cardio-circolatoria e Perfusione Cardiovascolare
Basi cellulari e molecolari della vita, modulo di Biologia Applicata (2cfu)
Ostetricia
Basi molecolari e cellulari della vita, modulo di Biologia applicata (2cfu)
2021/2022 Sapienza University of Rome Tecniche di Fisiopatologia Cardio-circolatoria e Perfusione Cardiovascolare
Basi cellulari e molecolari della vita, modulo di Biologia Applicata (2cfu)
Ostetricia
Basi molecolari e cellulari della vita, modulo di Biologia applicata (2cfu)
2022/2023 Sapienza University of Rome Medicine and Surgery (class F), Dentistry and Dental Prosthodontics
Biology and Genetics (4 cfu)
COURSE COORDINATOR (I semester)
Tecniche di Fisiopatologia Cardio-circolatoria e Perfusione Cardiovascolare
Basi cellulari e molecolari della vita, modulo di Biologia Applicata (2cfu)
Ostetricia
Basi molecolari e cellulari della vita, modulo di Biologia applicata (2cfu)
2023/2024 Sapienza University of Rome Medicine and Surgery (class F), Dentistry and Dental Prosthodontics
Biology and Genetics (10 cfu)
COURSE COORDINATOR (I and II semester)
Tecniche di Fisiopatologia Cardio-circolatoria e Perfusione Cardiovascolare
Basi cellulari e molecolari della vita, modulo di Biologia Applicata (2cfu)
Ostetricia
Basi molecolari e cellulari della vita, modulo di Biologia applicata (2cfu)

Other Teaching experiences
2013-2022 Participation to ADE/lessons:
Laurea Magistrale “A” in Medicina e Chirurgia e del corso di Laurea Magistrale in Biotecnologie Mediche
Corso di Laurea Magistrale a ciclo unico in Medicina e Chirurgia
Corso di Laurea Magistrale “C” e del corso di Laurea Magistrale “F” in Medicina e Chirurgia

ASN Simulation (2012-2024) (IRIS database)
Value Description Threshold
27 Numero articoli ultimi 5 anni 8 SECONDA FASCIA
1979 Numero citazioni ultimi 10 anni 307 SECONDA FASCIA
24 H index ultimi 10 anni 8 SECONDA FASCIA
47 Numero articoli ultimi 10 anni 23 PRIMA FASCIA
2122 Numero citazioni ultimi 15 anni 770 PRIMA FASCIA
26 H index ultimi 15 anni 15 PRIMA FASCIA
47 Numero articoli ultimi 10 anni 31 COMMISSARIO
2122 Numero citazioni ultimi 15 anni 1163 COMMISSARIO
26 H index ultimi 15 anni 19 COMMISSARIO

Supervision of thesis (National and International)
2017/2018 Sapienza University of Rome, Facoltà di farmacia e Medicina, Corso di laurea in Biotecnologie
2019/2020 Erasmus Degree Project
Sapienza University of Rome and Universitat de Barcelona (Spain)
2020/2021 Sapienza University of Rome, Facoltà di farmacia e Medicina, Corso di laurea in Biotecnologie mediche
2020/2021 Sapienza University of Rome, Facoltà di farmacia e Medicina, Corso di laurea in Farmacia
2023/2024 Sapienza University of Rome, Facoltà di farmacia e Medicina, Corso di laurea in Biotecnologie mediche
2023/2024 Sapienza University of Rome, Facoltà di farmacia e Medicina, Corso di laurea in Biotecnologie mediche

Participation to Doctorate programs
Sept.2019/today Sapienza University of Rome PhD program in Human Biology and Medical Genetics

Supervision of national and international PhD thesis
2020 Universität des Saarlandes (Germany) Thesis: Design and synthesis of novel ligands for serotonin (5-HT6) receptor and inhibitors of ABCB1 efflux pump
2021 Sapienza University of Rome Thesis: The RNA binding protein PCBP2 is a regulator of
miRNAs partition between cell and extracellular
vesicles

Supervision of Erasmus+ Students
2019/2020 Sapienza University of Rome and Universitat de Barcelona (Spain) Erasmus Degree Project: Exosome-mediated intercellular communication, the role of cellular RNA-binding proteins
2022 Istanbul Medeniyet University (Turkey) Erasmus Project: Study of the role of epitranscriptomic modifications in ncRNA sorting in EVs
2022 Istanbul Medeniyet University (Turkey) Erasmus Project: Study of the role of epitranscriptomic modifications in ncRNA-RBPs interaction
2023 Jagiellonian University (Poland) Erasmus PhD Project: Biological evaluation of the specificity and effectiveness of seleno-derivatives

Part V – Society memberships
Year Title
2015-today ABCD (Associazione di Biologia Cellulare e del Differenziamento)
2018-today Epigenetics Society
2013-2015 TEMTIA (The EMT International Association)
2020-today EVIta (Extracellular Vesicle Italy)

Oral Presentations
2-4/12/2024 INVITED SPEAKER 36th AICC International Meeting 2024 :“HIJACKING THE GOOD PATHWAYS: CANCER, IMMUNITY AND THERAPEUTIC APPROACHES”, Rome
28/11/2024 INVITED SPEAKER Recent advances in redox active species webinar On line event
17-18/10/2024 “Organelle biogenesis, signal transduction and trafficking” ABCD Meeting, Bologna
13-15/9/2023 3rd EVIta Symposium, Urbino
7-8/6/2021 INVITED SPEAKER III international AICC Exosome Meeting “Cell to cell delivery in cancer and therapy: a matter of carriers and messages” Virtual Event
6-8/11/2019 1st EVIta Symposium, Palermo
22-24/11/2018 ABCD Meeting: “Signal Transduction in Cancer”, Turin
23/11/2016 INVITED SPEAKER at the Bambino Gesù Children’s Hospital (Rome).
Seminar title: The Snail repressor recruits EZH2 to specific genomic sites through the enrolment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition
20-23/9/2016 – XIV FISV Congress – Rome 
30/9-1/10 2016 – XVII AIBG Congress – Cagliari
17-19/9/2015 – ABCD meeting – Bologna
7/9/2015 – RNA day 2015, the multi-faceted non coding RNA landscape – Rome
24-25-26-27/9/2014 – Congress FISV 2014- Pisa
12-13/9/2013 – Conference “RNA day 2013, the centrality of non coding RNA in gene-regulation”- Roma
12-13-14/10/2012 – 9° annual meeting IIM- Acaya, Lecce.
24-25-26/5/2012 – “Frontiers in molecular biology” SIBBM congress – Palermo.
4-5-6/6/2009 – “Frontiers in molecular biology” SIBBM Congress – Napoli.

Awards and Honors
Year Title
2019 EVIta (Extracellular Vesicle Italy) award (best oral presentation)
2018 AIRC award at the AIBG (Associazione Italiana Biologia e Genetica) Congress (young investigator award)
2013 TEMTIA (The EMT International Association) award (young investigator award)
2012 IIM (Italian Institute of Myology) award (best oral presentation)
2012 SIBBM (Società Italiana Biofisica Biologia Molecolare) award (best oral presentation)
2011 EMBO award (young investigator award)
2010 Collegio Ghislieri award (young investigator award)

Editorial activity
2016-2017
2017-2018 Academic Editor “Mediators of Inflammation”
Academic Editor “Frontiers in Pharmacology”
2019-2020 Academic Editor “Frontiers in Pharmacology”
2020 Academic Editor “Biomedicine”
2020 Associate Editor for the Cellular Biochemistry section of “Frontiers in Cell and Developmental Biology” and of “Frontiers in Molecular Biosciences”

Peer Review activity
Peer review activity for the following journals:
Cell death and Differentiation, Oncogene, Cancers, Sensors, Molecules, Molecular Cancer, International Journal of Molecular Sciences, Cancer Medicine, Experimental and Molecular Pathology, Cellular Physiology and Biochemistry, Clinics and Research in Hepatology and Gastroenterology, Cells, Cell communication and Signalling, International Journal of Cancer, Cell Death and Disease, Gene, Genes, Pharmaceuticals, Oxidative Medicine and Cellular longevity, Cancer Gene Therapy, Frontiers in Cell and Developmental Biology, Cancer Cell International, Cellular & Molecular Biology Letters.

Part VI – Research Funding Information [grants as PI-principal investigator or I-investigator]

Year Title Program
2008 “Differenziamento miogenico e neuronale: fattori di regolazione”. (I) Ricerche UNIVERSITARIE (ex ricerche di ATENEO) codice C26A082MNW.
2009-2011 Interplay between myogenic factors and cell cycle control. (I) Istituto Pasteur – Fondazione Cenci Bolognetti
2012-2014 Transcriptional regulation through long-range chromatin interactions in muscle cells: the CDKN1C-KCNQ1 locus. (I) Istituto Pasteur – Fondazione Cenci Bolognetti
2014-2016 Dissecting HNF4 and Snail functions in hepatocyte reprogramming: role in liver cancer and fibrosis (I) AIRC Investigator Grant n. IG14114
2017-2019 Developing ncRNAs-based strategies to counteract epithelial tumour progression and metastasis (I) AIRC Investigator Grant n. IG18843
2018 Study of tissue environmental cues inactivating the master regulator of hepatocyte differentiation, Hepatocyte Nuclear Factor 4, in liver diseases (I) Ricerche UNIVERSITARIE (ex ricerche di ATENEO) codice RM1181643646188C
2019 Molecular strategies to antagonise the epithelial to mesenchymal transition (EMT) by interfering with the function of the lncRNA Hotair (I) Ricerche UNIVERSITARIE (ex ricerche di ATENEO) codice RM11916B6A80C2CF
2020 Impact of autophagy on extracellular vesicle-mediated cell-to-cell communication in cancer (I) Ricerche UNIVERSITARIE (ex ricerche di ATENEO)
codice RG120172B73EDDC5
2021 Deciphering the role of m6A on HOTAIR function and EV-compartmentalization (PI) SEED PNR- Finanziamento di progetti di ricerca su temi di interesse trasversale per il PNR
2022 Piattaforma integrata per la generazione, la coltura e il differenziamento di cellule pluripotenti staminali indotte (cellule iPS) e organoidi (I) Ricerche UNIVERSITARIE codice MA2221815D2A0829
2022 Dissecting the role of m6A on miRNA function, EV-loading and EV-mediated cell-to-cell communication in hepatocellular carcinoma (PI) Ricerche UNIVERSITARIE
RM12218166AEFC72
2023 AGE - lT - A NOVEL PUBLIC PRIVATE ALLIANCE TO GENERATE SOCIOECONOMIC,
BIOMEDICAL AND TECHNOLOGICAL SOLUTIONS FOR AN INCLUSIVE ITALIAN
AGEING SOCIETY
(I) PNRR Partenariati estesi
2023 Tackling liver metastasis: dissecting the mechanistic role of small extracellular vesicles (S/EV) and exploiting their engineering for novel therapeutic approaches. (I) PRIN 2022
2024 “NanoSeAL” (PI) Sapienza-Rome Technopole per l’internazionalizzazione della ricerca

3rd mission Funding Information [grants as PI-principal investigator or I-investigator]

Year Title Program
2024 “Respira Sapienza! Scienze in sinergia e comunità attiva contro l'epidemia del vaping e del fumo di tabacco per la tutela della salute pubblica, la sostenibilità dell'ambiente e il benessere futuro”. (I) Ricerche UNIVERSITARIE codice TM124192E29DB113.

Part VII – Research Activities
Keywords Brief Description
Transcriptional factors
Cell plasticity
Chromatin
ncRNAs
Cell differentiation
Tumorigenesis
Epithelial-to-mesenchymal transition
Epigenetics I am interested in molecular mechanisms controlling cell plasticity. In particular I focused my investigation in mechanisms controlling cell differentiation, epithelial-to-mesenchymal transition and tumour onset and dissemination. My collaborators and I elucidated the role of MyoD in the control of p57 (a cyclin-dependent kinase inhibitor) during muscle differentiation through the direct binding to the chromatin, and of CTCF in the reorganization of chromatin structure in the same phenomenon. In three recent studies, I projected, developed and then elucidated with my team members the role and regulation of a lncRNA, HOTAIR, in the progression of epithelial-to-mesenchymal transition. Specifically, I found that this lncRNA binds to the chromatin, together with the transcriptional factor Snail, in order to recruit chromatin modifiers on the promoters of epithelial genes. Then I focused on its transcriptional regulation, mainly mediated by another transcriptional factor, HNF4a, that binds to its promoter and enhancer and modifies a higher-order chromatin structure promoting HOTAIR transcription. More recently I designed a strategy to counteract HOTAIR function in epithelial-to-mesenchymal transition through an RNA-based approach counteracting HOTAIR-Snail interaction and chromatin modifications on the promoter regions of Snail-target epithelial genes.
I am presently involved in research projects related to the identification of RNA-binding proteins interacting with microRNAs and responsible for microRNAs loading inside extracellular vesicles, specifically into exosomes. In this scenario I am also investigating the role of epitranscriptomics in modulating microRNA-protein interaction both in epithelial-to-mesenchymal transition and during differentiation.
Moreover, I have been implicated in the development and biological application of different epigenetic drugs able to modulate gene expression both in epithelial-to-mesenchymal transition and in tumorigenesis. With respect to this aspect, I focused on the use different inhibitors of chromatin modifiers (DNA methyltransferases, Histone deacetylases, Polycomb repressive complex 2) in order to verify whether they could restore epithelial cell features (and epithelial genes expression rescue) without affecting transcription factor binding to the promoters of several epithelial genes.

Scientific network:
Prof. Andres Ramos, University College of London
Dr. Daniel D’Andrea, School of Science and Technology, Nottingham Trent University, Nottingham
Prof. Antonello Mai, Sapienza University of Rome
Prof. Elisabetta Ferretti, Sapienza University of Rome
Prof. Frank J. Gonzalez, Center for Cancer Research, National Cancer Institute, Bethesda
Prof. Miguel A. Del Pozo, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid
Prof. Manuel Lopez-Cabrera, Centro De Biología Molecular Severo Ochoa, Madrid
Prof. Jadwiga Handzlik, Jagiellonian University, Kraków, Poland
Prof. Claus Jacob, Universität des Saarlandes, Saarbrücken, Germany
Dr. Chiara Agrati, Bambino Gesù Childrens’ Hospital, Rome
Prof. Gian Gaetano Tartaglia, IIT, Genova
Prof. Sangeun Lee, Universität des Saarlandes, Saarbrücken, Germany

Part VIII – Summary of Scientific Achievements (papers published from 2012 to 2024)

Product type Number Data Base
Papers [international] 58 Scopus
https://www.scopus.com/author/submit/profile.uri?authorId=55371458900
2012 2024
Papers [international] 60 Google Scholar
https://scholar.google.it/citations?user=RTOf_14AAAAJ&hl=it&authuser=1&o...
2012 2024

Scopus* Google Scholar*
Total Impact factor (anno di pubblicazione) 368.80 384.95
Impact factor per product 6.36 6.15
First name products 16 16
Last name products 11 13
Corresponding author products 13 15
Total Citations 1928 2441
Average Citations per Product 33.24 40.68
Hirsch (H) index 25 26
Normalized H index* 1.67 1.67
All data were updated on 12/4/2025
*H index divided by the academic seniority.

Part IX – Publications (scopus database):

1. MyoD regulates p57kip2 expression by interacting with a distant cis-element and modifying a higher order chromatin structure
Authors: A. Busanello*, C. Battistelli*, M. Carbone, C. Mostocotto and R. Maione
*First authors
Nucleic Acids Res.2012 Sep 1;40(17):8266-75. doi:10.1093/nar/gks619. Epub 2012 Jun 26. PMID: 22740650
Journal: Nucleic Acids Research; IF 2012: 8.278

2. Functional interplay between MyoD and CTCF in regulating long-range chromatin interactions during differentiation
Authors: C. Battistelli, A. Busanello and R. Maione
J Cell Sci. 2014 Sep 1;127(Pt 17):3757-67. doi: 10.1242/jcs.149427. Epub 2014 Jul 7. PMID: 25002401 Journal: Journal of Cell Science; IF 2014: 5.432

3. Spike-in SILAC proteomic approach reveals the vitronectin as an early molecular signature of liver fibrosis in hepatitis C infections with hepatic iron overload.
Authors: Montaldo C, Mattei S, Baiocchini A, Rotiroti N, Del Nonno F, Pucillo LP, Cozzolino AM, Battistelli C, Amicone L, Ippolito G, van Noort V, Conigliaro A, Alonzi T, Tripodi M, Mancone C.
Proteomics. 2014 May;14(9):1107-15. doi: 10.1002/pmic.201300422. PMID: 24616218
Journal: Proteomics; IF 2014 3.807

4. Poly(ADP-ribosyl)ation is required to modulate chromatin changes at c-MYC promoter during emergence from quiescence.
Authors: Mostocotto C, Carbone M, Battistelli C, Ciotti A, Amati P, Maione R.
PLoS One. 2014 Jul 21;9(7):e102575. doi: 10.1371/journal.pone.0102575. eCollection 2014. PMID: 25047032
Journal: Plos One; IF 2014 3.234

5. Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29
Authors: C. Cicchini, V. de Nonno, C. Battistelli, A. M. Cozzolino, M. De Santis Puzzonia, S. A. Ciafrè, C. Brocker, F. J. Gonzalez, L. Amicone, and M. Tripodi
Biochim Biophys Acta. 2015 Aug;1849(8):919-29. doi: 10.1016/j.bbagrm.2015.05.005. Epub 2015 May 21.
PMID: 26003733
Journal: Biochimica et Biophysica Acta - Gene Regulatory Mechanisms; IF 2015: 5.373

6. SETDB1 is a new promising target in HCC therapy.
Authors: Cicchini C, Battistelli C, Tripodi M.
Chin Clin Oncol. 2016 Dec;5(6):73. doi: 10.21037/cco.2016.05.04. Epub 2016 Jun 3. PMID: 27334461
Journal: Chin Clin Oncol.; IF 2016 n.d.

7. Modulating the Substrate Stiffness to Manipulate Differentiation of Resident Liver Stem Cells and to Improve the Differentiation State of Hepatocytes
Authors: A. M. Cozzolino, V. Noce, C. Battistelli, A. Marchetti, G. Grassi, C. Cicchini, M. Tripodi, and L. Amicone
Stem Cells Int. 2016;2016:5481493. doi: 10.1155/2016/5481493. Epub 2016 Jan 12. PMID: 27057172 Journal: Stem Cells International; IF 2016: 3.540

8. Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis
Authors: R. Strippoli, R. Moreno-Vicente, C. Battistelli, C. Cicchini, V. Noce, L. Amicone, A. Marchetti, M. A. del Pozo, and M. Tripodi
Stem Cells Int. 2016;2016:3543678. doi: 10.1155/2016/3543678. Epub 2016 Jan 31. PMID: 26941801 Journal: Stem Cells International; IF 2016: 3.540

9. The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting
Authors: L. Santangelo, G. Giurato, C. Cicchini, C. Montaldo, C. Mancone, R. Tarallo, C. Battistelli, T. Alonzi, A. Weisz, and M. Tripodi
Cell Rep. 2016 Oct 11;17(3):799-808. doi: 10.1016/j.celrep.2016.09.031. PMID: 27732855
Journal: Cell Reports; IF 2016: 8.282

10. A cross-talk between DNA methylation and H3 lysine 9 dimethylation at the KvDMR1 region controls the induction of Cdkn1c in muscle cells
Authors: O. Andresini, A. Ciotti, M. N. Rossi, C. Battistelli, M. Carbone, and R. Maione
Epigenetics. 2016 Nov;11(11):791-803. doi: 10.1080/15592294.2016.1230576. Epub 2016 Sep 9. PMID: 27611768
Journal: Epigenetics; IF 2016: 4.394

11. Promotion of proliferation and metastasis of hepatocellular carcinoma by LncRNA00673 based on the targeted-regulation of notch signaling pathway
Authors: P Magistri, C Battistelli, G Assirati, F Mereu, G Tarantino, G P Guerrini, R Ballarin, F Di Benedetto
Eur Rev Med Pharmacol Sci. 2017 Oct;21(19):4261-4262. PMID: 29077173
Journal: Eur Rev Med Pharmacol Sci. IF 2017: 2.387

12. Targeting of polycombs to DNA in EMT.
Authors: Battistelli C, Tripodi M, Cicchini C.
Oncotarget. 2017 Aug 12;8(35):57936-57937. doi: 10.18632/oncotarget.20211. eCollection 2017 Aug 29.
PMID: 28938527
Journal: Oncotarget; IF 2017 n.d.

13. Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma
Authors: L. Santangelo, C. Battistelli, C. Montaldo, F. Citarella, R. Strippoli and C. Cicchini
Biomed Res Int. 2017;2017:2931813. doi: 10.1155/2017/2931813. Epub 2017 Feb 7. PMID: 28265569
Journal: BioMed Research International; IF 2017: 2.583

14. The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition
Authors: C. Battistelli, C. Cicchini, L. Santangelo, A. Tramontano, L. Grassi, F. J. Gonzalez, V. de Nonno, G. Grassi, L. Amicone and M. Tripodi
Oncogene. 2017 Feb 16;36(7):942-955. doi: 10.1038/onc.2016.260. Epub 2016 Jul 25. PMID: 27452518
Journal: Oncogene; IF 2017: 6.854

15. The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter.
Authors: Fazi, B, Garbo, S, Toschi, N, Mangiola, A, Lombari, M, Sicari, D, Battistelli, C, Galardi, S, Michienzi, A, Trevisi, G, Harari-Steinfeld, R, Cicchini, C, Ciafrè, SA.
Oncotarget. 2018 Feb 14;9(21):15512-15525. doi: 10.18632/oncotarget.24496. eCollection 2018 Mar 20. PMID: 29643989
Journal: Oncotarget; IF 2018 n.d

16. SMO inhibition modulates cellular plasticity and invasiveness in colorectal cancer
Authors: P. Magistri*, C. Battistelli*, R. Strippoli, N. Petrucciani, T. Pellinen, L. Rossi, L. Mangogna, P. Aurello, F. D’Angelo, M. Tripodi, G. Ramacciato and G. Nigri
*First authors
Front Pharmacol. 2018 Feb 2;8:956. doi: 10.3389/fphar.2017.00956. eCollection 2017. PMID: 29456503
Journal: Frontiers in Pharmacology; IF 2018: 3.831

17. Hepatitis C virus direct-acting antivirals therapy impacts on extracellular vesicles microRNAs content and on their immunomodulating properties
Authors: L. Santangelo, V. Bordoni, C. Montaldo, E. Cimini, A. Zingoni, C. Battistelli, G. D’Offizi, M. R. Capobianchi, A. Santoni, M. Tripodi and C. Agrati
Liver Int. 2018 Oct;38(10):1741-1750. doi: 10.1111/liv.13700. Epub 2018 Feb 24. PMID: 29359389
Journal: Liver International; IF 2018: 5.542

18. HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal
Authors: L. Rossi*, C. Battistelli*, V. de Turris, V. Noce, C. Zwergel, S. Valente, A. Moioli, A. Manzione, M. Palladino, V. Bordoni, A. Domenici, P. Menè, A. Mai, M. Tripodi and R. Strippoli
*First authors
Sci Rep. 2018 May 31;8(1):8492. doi: 10.1038/s41598-018-26319-2. PMID: 29855565
Journal: Scientific Reports; IF 2018: 4.011

19. A cryptic RNA-binding domain mediates Syncrip recognition and exosomal partitioning of miRNA targets
Authors: F. Hobor, A. Dallmann, N. J. Ball, C. Cicchini, C. Battistelli, R. W. Ogrodowicz, E. Christodoulou, S. R. Martin, A. Castello, M. Tripodi, I. A. Taylor and A. Ramos
Nat Commun. 2018 Feb 26;9(1):831. doi: 10.1038/s41467-018-03182-3. PMID: 29483512
Journal: Nature Communications; IF 2018: 11.878

20. TGFβ impairs HNF1α functional activity in Epithelial-to-Mesenchymal Transition interfering with the recruitment of CBP/p300 acetyltransferases
Authors: F. Bisceglia*, C. Battistelli*, V. Noce, C. Montaldo, A. Zammataro, R. Strippoli, M. Tripodi, L. Amicone and A. Marchetti
*First authors
Front Pharmacol. 2019 Aug 30;10:942. doi: 10.3389/fphar.2019.00942. eCollection 2019. PMID: 31543815 Journal: Frontiers in Pharmacology; IF 2019: 4.225

21. Development of alkyl glycerone phosphate synthase inhibitors: Structure-activity relationship and effects on ether lipids and epithelial-mesenchymal transition in cancer cells
Authors: G. Stazi*, C. Battistelli*, V. Piano, R. Mazzone, B. Marrocco, S. Marchese, S. M. Louie, C. Zwergel, L. Antonini, A. Patsilinakos, R. Ragno, M. Viviano, G. Sbardella, A. Ciogli, G. Fabrizi, R. Cirilli, R. Strippoli, A. Marchetti, M. Tripodi, D. K. Nomura, A. Mattevi, A. Mai and S. Valente
*First authors
Eur J Med Chem. 2019 Feb 1;163:722-735. doi: 10.1016/j.ejmech.2018.11.050. Epub 2018 Nov 28. PMID: 30576903
Journal: European Journal of Medicinal Chemistry; IF 2019: 5.572

22. The lncRNA HOTAIR transcription is controlled by HNF4α-induced chromatin topology modulation
Authors: C. Battistelli, G. Sabarese, L. Santangelo, C. Montaldo, F. J. Gonzalez, M. Tripodi and C. Cicchini
Cell Death Differ. 2019 May;26(5):890-901. doi: 10.1038/s41418-018-0170-z. Epub 2018 Aug 28. PMID: 30154449
Journal: Cell Death and Differentiation; IF 2019: 10.717

23. Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
Authors: C. Zwergel, M. Schnekenburger, F. Sarno, C. Battistelli, M. C. Manara, G. Stazi, R. Mazzone, R. Fioravanti, C. Gros, F. Ausseil, C. Florean, A. Nebbioso, R. Strippoli, T. Ushijima, K. Scotlandi, M. Tripodi, P. B. Arimondo, L. Altucci, M. Diederich, A. Mai and S. Valente
Clin Epigenetics. 2019 May 6;11(1):68. doi: 10.1186/s13148-019-0663-8. PMID: 31060628
Journal: Clinical Epigenetics; IF 2019: 5.028

24. YAP integrates the regulatory Snail/HNF4α circuitry controlling epithelial/hepatocyte differentiation.
Authors: Noce V, Battistelli C, Cozzolino AM, Consalvi V, Cicchini C, Strippoli R, Tripodi M, Marchetti A, Amicone L.
Cell Death Dis. 2019 Oct 10;10(10):768. doi: 10.1038/s41419-019-2000-8. PMID: 31601778
Journal: Cell Death and Disease; IF 2019: 6.304

25. Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis.
Authors: Battistelli C, Diederich M, Keane TJ, Sandoval P, Valente S, Strippoli R.
Front Pharmacol. 2020 Jan 16;10:1556. doi: 10.3389/fphar.2019.01556. eCollection 2019. PMID: 32009960
Journal: Frontiers in Pharmacology; IF 2020: 4.225

26. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation.
Authors: Zwergel C, Fioravanti R, Stazi G, Sarno F, Battistelli C, Romanelli A, Nebbioso A, Mendes E, Paulo A, Strippoli R, Tripodi M, Pechalrieu D, Arimondo PB, De Luca T, Del Bufalo D, Trisciuoglio D, Altucci L, Valente S, Mai A.
Cancers (Basel). 2020 Feb 14;12(2):447. doi: 10.3390/cancers12020447. PMID: 32075099
Journal: Cancers; IF 2020: 6.126

27. Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer Cells.
Authors: Romanelli A, Stazi G, Fioravanti R, Zwergel C, Di Bello E, Pomella S, Perrone C, Battistelli C, Strippoli R, Tripodi M, Del Bufalo D, Rota R, Trisciuoglio D, Mai A, Valente S.
ACS Med Chem Lett. 2020 Mar 19;11(5):977-983. doi: 10.1021/acsmedchemlett.0c00014. eCollection 2020 May 14. PMID: 32435414
Journal: ACS Medicinal Chemistry Letters; IF 2020: 3.975

28. Caveolin1 and YAP drive mechanically-induced mesothelial to mesenchymal transition and fibrosis
Authors: R. Strippoli, P. Sandoval, R. Moreno-Vicente, L. Rossi, C. Battistelli, M. Terri, L. Pascual-Antón, M. Loureiro, F. Matteini, E. Calvo, J. A. Jiménez-Heffernan, M. J. Gómez, V. Jiménez-Jiménez, F. Sánchez-Cabo, J. Vázquez, M. Tripodi, M. López-Cabrera and M. Á. del Pozo
Cell Death Dis. 2020 Aug 3;11(8):647. doi: 10.1038/s41419-020-02822-1. PMID: 32811813
Journal: Cell Death and Disease; IF 2020: 6.304

29. Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma.
Authors: Ali W, Spengler G, Kincses A, Nové M, Battistelli C, Latacz G, Starek M, Dąbrowska M, Honkisz-Orzechowska E, Romanelli A, Rasile MM, Szymańska E, Jacob C, Zwergel C, Handzlik J.
Eur J Med Chem. 2020 Aug 15;200:112435. doi: 10.1016/j.ejmech.2020.112435. Epub 2020 May 15. PMID: 32505850
Journal: European Journal of Medicinal Chemistry; IF 2020: 5.572

30. Poly(ADP-ribose) Polymerase 1 (PARP1) restrains MyoD-dependent gene expression during muscle differentiation.
Authors: Matteini F, Andresini O, Petrai S, Battistelli C, Rossi MN, Maione R.
Sci Rep. 2020 Sep 15;10(1):15086. doi: 10.1038/s41598-020-72155-8. PMID: 32934320
Journal: Scientific Reports; IF 2020: 3.998

31. Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis (volume II)
Authors: Battistelli C, Diederich M, Keane TJ, Sandoval P, Valente S, Strippoli R.
Front Pharmacol. 2020 Jan 16;10:1556. doi: 10.3389/fphar.2019.01556. eCollection 2019. PMID: 32009960
Journal: Frontiers in Pharmacology; IF 2022: 4.225

32. Design and functional validation of a mutant variant of the lncRNA HOTAIR to counteract Snail function in Epithelial-to-Mesenchymal Transition
Authors: C. Battistelli#, S. Garbo, V. Riccioni, C. Montaldo, L. Santangelo, A. Vandelli, R. Strippoli, G. G. Tartaglia, M. Tripodi# and C. Cicchini
#Corresponding authors
Cancer Res. 2021 Jan 1;81(1):103-113. doi: 10.1158/0008-5472.CAN-20-1764. Epub 2020 Nov 6.
PMID: 33158813 Journal: Cancer Research; IF 2021: 13.312

33. The innovative potential of selenium-containing agents for fighting cancer and viral infections
Authors: W. Ali, R. Benedetti, J. Handzlik, C. Zwergel and C. Battistelli
Drug Discov Today. 2021 Jan;26(1):256-263. doi: 10.1016/j.drudis.2020.10.014. Epub 2020 Oct 23.
PMID: 33164821
Journal: Drug Discovery Today; IF 2021: 8.369

34. Nutlin-3a enhances Natural Killer cell-mediated killing of neuroblastoma by restoring p53-dependent expression of ligands for NKG2D and DNAM-1 receptors
Authors: I. Veneziani, P. Infante, E. Ferretti, O. Melaiu, C. Battistelli, V. Lucarini, M. Compagnone, C. Nicoletti, A. Castellano, S. Petrini, M. Ognibene, A. Pezzolo, L. Di Marcotullio, L. Moretta, R. Bei, V. Pistoia, D. Fruci, V. Barnaba, F. Locatelli, and L. Cifaldi
Cancer Immunology Research, 2021, 9(2), pp. 170–183
Journal: Cancer Immunology Resarch, IF 2020: 12.020

35. Natural Product Epigenetic Modulators and Inhibitors
Authors: Ntie-Kang, F., Karaman Mayack, B., Valente, S., Battistelli, C.
Frontiers in Pharmacology, 2021, 12, 651395
Journal: Frontiers in Pharmacology; IF 2020: 5.988

36. New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology.
Authors: Battistelli C, Cordani M, Diederich M, Somoza Á, Valente S, Strippoli R.
Front Pharmacol. 2021 Aug 6;12:742777. doi: 10.3389/fphar.2021.742777. eCollection 2021
Journal: Frontiers in Pharmacology; IF 2020: 5.988

37. m6A RNA methylation and beyond–the epigenetic machinery and potential treatment options
Authors: Garbo, S., Zwergel, C., Battistelli, C.
Drug Discov Today. 2021 Nov;26(11):2559-2574. doi: 10.1016/j.drudis.2021.06.004. Epub 2021 Jun 12.
Journal: Drug discovery today; IF 2021: 8.369

38. Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response.
Authors: Montaldo, C., Terri, M., Riccioni, V., Battistelli, C., Bordoni, V., D'Offizi, G., Prado, M.G., Trionfetti, F., Vescovo, T., Tartaglia, E., Strippoli, R., Agrati, C., Tripodi M.
J Hepatol. 2021 Dec;75(6):1301-1311. doi: 10.1016/j.jhep.2021.07.003. Epub 2021 Jul 13.
Journal: Journal of Hepatology; IF 2021: 30.083

39. SYNCRIP Modulates the Epithelial-Mesenchymal Transition in Hepatocytes and HCC Cells
Authors: Riccioni, V., Trionfetti, F., Montaldo, C., Garbo, S., Marocco, F., Battistelli, C., Marchetti, A., Strippoli, R., Amicone, L., Cicchini, C., Tripodi, M.
Int J Mol Sci. 2022 Jan 14;23(2):913. doi: 10.3390/ijms23020913.
Journal: International Journal of Molecular Sciences; IF 2021: 6.208

40. Next RNA Therapeutics: The mine of non-coding
Authors: Garbo, S., Maione, R., Tripodi, M.#, Battistelli, C#.
#Corresponding authors
Int J Mol Sci. 2022 Jul 5;23(13):7471. doi: 10.3390/ijms23137471.
Journal: International Journal of Molecular Sciences; IF 2021: 6.208

41. Persistence of fibrogenic process in direct-acting antiviral (DAA) treated patients?
Authors: Battistelli, C., Tripodi M.
ExRNA 2022 Open Access Volume 4 June 2022 Article number 15
Journal: ExRNA, IF 2020:

42. Seleno- vs thioether triazine derivatives in search for new anticancer agents overcoming multidrug resistance
Authors: Ali, W., Garbo, S., Spengler, G., Di Bello, E., Honkisz-Orzechowska, E., Karcz, T., Szymańsk, E., Żesławska, E., Starek, M., Dąbrowska, M., Nitek, W., Kucwaj-Brysz, K., Pyka, P., Haberek, W., Fioravanti, R., Jacob, C., Battistelli, C.#, Zwergel, C. #, Handzlik, J. #
#Corresponding authors
Journal: European Journal of Medicinal Chemistry; IF 2022: 6.525

43. A novel microRNA signature for the detection of melanoma by liquid biopsy
Authors: Sabato, C., Noviello, T.M.R., Covre, A., Coral, S., Caruso, F.P., Mersini Besharat, Z., Splendiani, E., Masuelli, L., Battistelli, C., Vacca, A., Catanzaro, G., Po, A., Anichini, A., Maio, M., Ceccarelli, M., Di Giacomo, A.M. and Ferretti, E.
Journal: Journal of Translational medicine; IF 2022: 5.531

44. MyoD-induced trans-differentiation: a paradigm for dissecting the molecular mechanisms of cell commitment, differentiation and reprogramming
Authors: Battistelli, C., Garbo, S., and Maione, R.
Journal: Cells; IF 2022: 7.666

45. Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells
Authors: Bontempi, G., Terri, M., Garbo, S., Montaldo, C., Mariotti, D., Bordoni, V., Valente, S., Zwergel, C., Mai, A., Marchetti, A., Domenici, A., Mene, P., Battistelli, C., Tripodi, M., Strippoli, R.
Journal: Cell death and disease; IF 2022: 9.705

46. Extracellular signal-Regulated Kinase 5 (ERK5) is required for the Yes-associated protein (YAP) co-transcriptional activity
Authors: Ippolito, F., Consalvi, V., Noce, V., Battistelli, C., Cicchini, C., Tripodi, M., Amicone, L., Marchetti,A.
Journal: Cell death and disease; IF 2022: 9.705

47. Selenium-containing agents acting on cancer- a new hope?
Authors: Garbo, S., Di Giacomo, S. Łażewska, D., Honkisz-Orzechowska, E., Di Sotto, A., Fioravanti, R., Zwergel, C.* and Battistelli, C.*
*Corresponding authors
Journal: Pharmaceutics; IF 2022: 6.525

48. In vivo Bioluminescence-Based Monitoring of Liver Metastases from Colorectal Cancer: An Experimental Model.
Authors: Magistri, P.*, Battistelli, C.*, Toietta, G*, Strippoli, R., Sagnotta, A., Forgione, A., Di Benedetto, F., Uccini, S., Vittorioso, P., D'Angelo, F., Aurello, P., Ramacciato, G., Nigri, G.
*First authors
J Microsc Ultrastruct. 2019 Jul-Sep;7(3):136-140. doi: 10.4103/JMAU.JMAU_51_18.
Journal: J Microsc Ultrastruct; IF 2022: 6.525

49. Novel 1,4-Dihydropyridines as Specific Binders and Activators of Sirt3 Impair Cell Viability and Clonogenicity, and Downregulate Hypoxia-Induced Targets in Cancer Cells
Authors: Zwergel, C., Aventaggiato, M., Garbo, S., Di Bello, E., Fassari, B., Noce, B., Castiello, C., Lambona, C., Barreca, F., Rotili, D., Fioravanti, R., Schmalz, T., Weyand, M., Niedermeier, A., Tripodi, M., Colotti, G., Steegborn, C., Battistelli, C.*, Tafani, M.*, Valente, S.*, Mai, A.
*Corresponding authors
J Med Chem. 2023 Jul 27;66(14):9622-9641. doi: 10.1021/acs.jmedchem.3c00337. Epub 2023 Jul 13.
Journal: Journal of Medicinal Chemistry; IF 2022: 7.300

50) Correction to Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
Authors: C. Zwergel, M. Schnekenburger, F. Sarno, C. Battistelli, M. C. Manara, G. Stazi, R. Mazzone, R. Fioravanti, C. Gros, F. Ausseil, C. Florean, A. Nebbioso, R. Strippoli, T. Ushijima, K. Scotlandi, M. Tripodi, P. B. Arimondo, L. Altucci, M. Diederich, A. Mai and S. Valente
Clin Epigenetics. 2022 Sep 28;14(1):119. doi: 10.1186/s13148-022-01339-y.
Journal: Clinical Epigenetics; IF 2022: 5.028

51) Interaction of Garcinia cambogia (Gaertn.) Desr. and Drugs as a Possible Mechanism of Liver Injury: The Case of Montelukast
Authors: Di Giacomo, S., Di Sotto, A., Percaccio, E., Scuotto, E., Battistelli, C., Mazzanti, G., Menniti-Ippolito, F., Ippoliti, I.
Antioxidants (Basel). 2023 Sep 16;12(9):1771. doi: 10.3390/antiox12091771.
Journal: Antioxidant; IF 2022: 7.000

52) HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells
Authors: Trionfetti, F., Alonzi, T., Terri, M., Bontempi, G., Battistelli, C., Montaldo, C., Repele, F., Rotili, D., Valente, S., Zwergel, C., Matusali, G., Maggi, F., Goletti, D., Tripodi, M., Mai, A., Strippoli, R.
Journal: Front. Cell. Infect. Microbiol.; IF 2022: 5.700

53) First-in-class Selenium-containing potent serotonin receptor 5-HT6 agents with a beneficial neuroprotective profile against Alzheimer’s disease
Authors: Pyka, P., Haberek, W., Więcek, M., Szymańska, E., Ali, W., Cios, A., Jastrzębska-Więsek, M., Satała, G., Podlewska, S., Di Giacomo, S., Di Sotto, A., Garbo, S., Lambona, C., Marocco, F., Mordyl, B., Głuch-Lutwin, M., Sudoł-Tałaj S., Czarnota-Łydka, K., Gogola, D., Latacz, G., Wilczyńska-Zawal, N., Honkisz-
Orzechowska, E., Starek, M., Dąbrowska, M., Kucwaj-Brysz, K., Fioravanti, R., Nasim, M.J., Hittinger, M., Partyka, A., Wesołowska, A., Battistelli, C.*, Zwergel, C.*, Handzlik, J*.
*Corresponding authors
Journal: Journal of Medicinal Chemistry; IF 2022: 7.300

54) HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling
Authors: Terri, M., Sandoval, P., De Turris, V., Montaldo, C., Trionfetti, F., Bontempi, G., Tomero-Sanz, H., Pascual Anton, L., Clares Pedrero, I., Battistelli, C., Valente, S., Zwergel, C., Mai, A., Rosano, L., Sánchez Álvarez, M., Del Pozo Barriuso, M. A., Cabañas, C., Tripodi, M., López-Cabrera, M., Strippoli, R.
Journal: Journal of Experimental & Clinical Cancer Research; IF 2022: 11.300

55) Correction to Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation (Cancers, (2020), 12, 2, (447), 10.3390/cancers12020447)
Authors: Zwergel C, Fioravanti R, Stazi G, Sarno F, Battistelli C, Romanelli A, Nebbioso A, Mendes E, Paulo A, Strippoli R, Tripodi M, Pechalrieu D, Arimondo PB, De Luca T, Del Bufalo D, Trisciuoglio D, Altucci L, Valente S, Mai A.
Cancers (Basel). 2024 Mar 21;16(6):1230. doi: 10.3390/cancers16061230.
Journal: Cancers; IF 2020: 6.126

56) m6A modification inhibits miRNAs’ intracellular function, favoring their extracellular export for intercellular communication
Authors: Garbo, S., D’Andrea, D., Tartaglia, G. G., Ramos, A., Tripodi, M.#, Battistelli, C#.
#Corresponding authors
Cell Rep. 2024 Jun 14;43(6):114369. doi: 10.1016/j.celrep.2024.114369.
Journal: Cell reports; IF 2022: 8.8

57) Selenium-containing compounds: a new hope for innovative treatments in Alzheimer's disease and Parkinson's disease.
Authors: Pyka, P.*, Garbo, S.*, Fioravanti, R., Jacob, C., Hittinger, M., Handzlik, J. #, Zwergel, C. #, Battistelli, C. #
*First authors
#Corresponding authors
Drug Discov Today. 2024 Jun 11;29(8):104062. doi: 10.1016/j.drudis.2024.104062.
Journal: Drug discovery today; IF 2022: 8.369

58) Unlocking the Potential of Higher-Molecular-Weight 5-HT7R Ligands: Synthesis, Affinity, and ADMET Examination
Authors: Pyka, P.*, Garbo, S.*, Murzyn, A., Satała, G., Janusz, A., Górka, M., Pietruś, W., Mituła, F., Popiel, D., Wieczorek, M., Palmisano, B., Zwergel, C., Szymańska, E., Kucwaj-Brysz, K., Battistelli, C. #, Handzlik, J. #, Podlewska, S#.
*First authors; #Corresponding authors
Bioorganic Chemistry; 22 July 2024. https://doi.org/10.1016/j.bioorg.2024.107668
Journal: Bioorganic Chemistry; IF 2022: 5.1

59) Procognitive potential of neuroprotective triazine 5-HT6 receptor antagonists tested on chronic activity in vivo in rats: Computer-aided insight into the role of chalcogen-differences on the pharmacological profile
Authors: Jastrzębska-Więsek, M., Garbo, S.*, Cios, A., Wilczyńska-Zawal N., Partyka A., Honkisz-Orzechowska, E., Żesławska, E., Handzlik, J., Mordyl, B., Głuch-Lutwin, M., Raucci, A., Hittinger, M., Starek, M., Dąbrowska, M., Nitek, W., Karcz, T., Skorkowska, A., Gdula-Argasińska, J., Czarnota-Łydka, K., Pyka, P., Szymanska, E., Kucwaj-Brysz, K., Zwergel, C., Wesołowska, A., Battistelli, C.#, Handzlik, J.#
*First authors; #Corresponding authors
ACS Chemical Neuroscience;
Journal: ACS Chemical Neuroscience; IF 2023: 4.1

Other publications (pubmed database):

59) A novel RNA-based approach to counteract EMT.
Authors: Garbo, S., Tripodi, M., Battistelli, C.
Oncoscience. 2021 May 7;8:53-54. doi: 10.18632/oncoscience.532. eCollection 2021.

60) lncRNA HOTAIR functions and therapeutic perspectives
Authors: Garbo, S., Tripodi, M., and Battistelli, C.
Oncoscience. 2022

Rome 12/4/2025